Nom du produit:[(1S)-1-[(7-bromo-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)methylamino]ethyl]phosphonic acid;hydrochloride

IUPAC Name:[(1S)-1-{[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]amino}ethyl]phosphonic acid hydrochloride

CAS:1135278-54-4
Formule moléculaire:C11H14BrClN3O5P
Pureté:95%+
Numéro de catalogue:CM781409
Poids moléculaire:414.58

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1135278-54-4
Formule moléculaire:C11H14BrClN3O5P
Point de fusion:-
Code SMILES:Cl.C[C@@H](NCC1=CC(Br)=CC2=C1NC(=O)C(=O)N2)P(O)(O)=O
Densité:
Numéro de catalogue:CM781409
Poids moléculaire:414.58
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.